$SPCX

SpaceX Gains 2% as Morgan Stanley Sees a Closing Window; AST SpaceMobile Surges 8%, Rocket Lab Rises 5%

Morgan Stanley's positive note on SpaceX's compute side lifted shares of SpaceX (up 2% to $174.67), AST SpaceMobile (up 8% to $63.34), and Rocket Lab (up 5% to $76.31). Analyst Adam Jonas set a $300 target, citing undervalued compute and chipmaking segments. The Procure Space ETF (UFO) rose 2%, outpacing the S&P 500's 0.6% gain.

Original reporting
Published Oct 6, 2026, 2:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 2:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX Gains 2% as Morgan Stanley Sees a Closing Window; AST SpaceMobile Surges 8%, Rocket Lab Rises 5% — source image
Decision brief

The 30-second read

$SPCXBullishMed
01

Why it matters

The upgrade spurs a short‑term rally across space stocks, but the sustainability depends on the upcoming test flight.

02

Market read

The article provides fresh analyst coverage that moves multiple listed space companies, offering a timely trading angle.

03

What to watch

The note focuses on compute/chipmaking, a segment with limited visibility and higher risk.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Morgan Stanley’s note highlights undervaluation of SpaceX’s compute business and a narrow window before the next Starship test.

Company-level read

Ticker impact

$SPCXBullishHigh confidence
Context

Morgan Stanley issued an Outperform note with a $300 target, driving SPCX up 2% in morning trade.

Expected impact

likely upward as investors price in the limited window thesis

Evidence & confidence

The note is fresh and ties to an upcoming Starship test, giving a concrete catalyst.

$ASTSBullishMedium confidence
Context

ASTS rose 8% as investors followed the SpaceX note, despite no company‑specific news.

Expected impact

potential pullback if the SpaceX catalyst fades

Evidence & confidence

Gain is sentiment‑driven rather than based on new ASTS fundamentals.

$RKLBBullishMedium confidence
Context

RKLB gained 5% on the same sector enthusiasm sparked by the SPCX analyst note.

Expected impact

may stabilize after the initial rally subsides

Evidence & confidence

Price move is linked to broader space‑sector sentiment, not a direct catalyst.

Market effects

Analyst coverage of SpaceX may lift the entire commercial‑space sector, benefitting peers.

U.S. investors showing heightened interest in space‑related equities.

Potential spillover to international space firms and related ETFs.

Counterpoint

If the Starship test is delayed, the analyst thesis could unravel, prompting a rapid sell‑off.

Key entities

  • Morgan Stanley

    Issued the Outperform note on SpaceX.

  • SpaceX

    Subject of the analyst note and upcoming Starship test.

Related articles

$RKLBHighAI 9/10

SpaceX Comfortably Wins on Scale. Here’s How Rocket Lab Still Competes.

Iridium shareholders approved Rocket Lab's $8B acquisition, with 99.6% voting in favor. Rocket Lab (RKLB) will operate a large satellite network. SpaceX (SPCX) grew Starlink subscribers to 12M, with Connectivity revenue up 66% to $4.29B. Rocket Lab competes by offering satellite services to other companies, with lower costs and faster deployment. SpaceX focuses on its own network and cheaper launches with Starship.

$SPCXLow

SpaceX (SPCX) Completed Starship Flight 14 To Low Earth Orbit

SpaceX (SPCX) completed Starship Flight 14 to low Earth orbit, deploying Starlink satellites. The company is in advanced talks with TSMC for custom AI chips and partnered with Beeline Kazakhstan for Direct to Cell services. SpaceX has a $2.3 trillion market cap and focuses on satellite broadband. Progress in Starship and AI chips supports infrastructure control, but regulatory and cash runway concerns persist.

$SPCXMedAI 8/10

Rush Street Interactive Stock Suddenly Sinks After Hot Rally

SpaceX (SPCX) stock fell 2% after-hours on reports of a $40B financing plan for Nvidia chips, following an 18% rally. Analyst Daniel Ives initiated coverage with an Outperform rating and $225 price target, citing synergies across SpaceX's businesses. Q2 revenue rose 92% to $7.81B, with AI sales up 247% to $2.56B. The company has a Strong Buy consensus rating with a $215.29 average price target.